⌘K

Login Start Free

Home/Filings/4/0001493152-20-021179

4//SEC Filing

Lacy John III 4

Accession 0001493152-20-021179

CIK 0000315545other

View on SEC.gov Company Profile

Filed

Nov 11, 7:00 PM ET

Accepted

Nov 12, 8:04 PM ET

Size

7.6 KB

Accession

0001493152-20-021179

Insider Transaction Report

Form 4

Period: 2020-11-10

PROVECTUS BIOPHARMACEUTICALS, INC.PVCT

Director

Transactions

Award
Common Stock
2020-11-10+100,000→ 200,000 total
Award
Stock Options (Right to Buy)
2020-11-10+100,000→ 100,000 total
Exercise: $0.29From: 2020-11-10Exp: 2025-11-10→ Common Stock (100,000 underlying)

Holdings

Common Stock
(indirect: By Spouse)
450

Documents

1 file

4
ownership.xmlPrimary

Issuer

PROVECTUS BIOPHARMACEUTICALS, INC.

CIK 0000315545

Entity typeother

Related Parties

1

filerCIK 0001739761

Filing Metadata

Form type: 4
Filed: Nov 11, 7:00 PM ET
Accepted: Nov 12, 8:04 PM ET
Size: 7.6 KB

View on SEC.gov